ArticleCancer research2026

Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies.

Daniel Ortega-Álvarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.